A drug-resistant type of bacteria that has adapted to health care settings evolved in the past several years to weaponize an ...

V-161, a novel compound targeting the Na + -V-ATPase enzyme in vancomycin-resistant Enterococcus faecium (VRE), significantly ...

Mills focused on vancomycin-resistant Enterococcus faecium (VREfm), so-called because it can’t be eradicated with the popular antibiotic vancomycin.

New research suggests that VREfm have the ability to produce bacteriocin, an antimicrobial that can kill or inhibit other ...

When exposed to antibiotics, approximately one out of every 10 8 -10 9 bacteria develops resistance due to spontaneous ...

A drug-resistant type of bacteria that has adapted to health care settings evolved in the past several years to weaponize an antimicrobial genetic tool, eliminating its cousins and replacing them as ...

Certain antibiotic-resistant infections could be treated with precision medicine in the future, thanks to a new resource mapping plasmids the ultimate vehicle of rapid bacterial evolution.

There’s an arms race in medicine – scientists design drugs to treat lethal bacterial infections, but bacteria can evolve defenses to those drugs, sending the researchers back to square one. In the ...

A newfound ability to produce an antibiotic helped a strain of antibiotic-resistant bacteria to take over a hospital.

Recent worldwide emergence of CA-MRSA has prompted the development of several new antibiotics (see Table 2). In the past, as vancomycin became less effective against MRSA, clinicians turned to ...

A Chinese research team has successfully developed a triplex real-time quantitative fluorescence PCR method capable of ...